EGFR and neoplasm: Other curcumin delivery methods and their corresponding tumor magnitude percentile reductions were as follows: HA@CUR-NCs (86%) [47], CUR-NP-biotin (79%) [60], curcumin + 5-FU (53.3%) [42], CUR-NP- AnxA2 (44.0%) [66], CUR-NP-PEI-HA (50%) [3], HA-Hybrid NPs/CUR (43.8%) [78], PPBV micelles/CUR (58.5%) [79], CUR-NP-FA (51–86%) [57,62,69], CUR-NP-PAE (65.6%) [82], CUR@ZIF-8@HA (62.5%) [81], and CUR-NP-EGFR (59.1%) [55].